Viridian Therapeutics, Inc. Common Stock Share Price
NASDAQ: VRDNHealthcare
Live Viridian Therapeutics, Inc. Common Stock Share Price Chart
O H L
Viridian Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$18.25Low
$18.69High
Markets Today
| Previous Close | $18.34 |
|---|---|
| Open | $18.37 |
| Volume | 1,333,912 |
| Day's Range | $18.25 - $18.69 |
| 52W Range | NA |
| Market Cap | $2.08 B |
Historical Performance
| 1M Returns | -16.29 |
|---|---|
| 3M Returns | -5.47 |
| 6M Returns | +24.82 |
| 1Y Returns | -11.10 |
| 5Y Returns | +19.23 |
| 10Y Returns | NA |
Viridian Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $2.08 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $70.85 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-362.94 M |
| Profit Margin | -397.93 |
| Market Cap | $2.08 B |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $70.85 M |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-362.94 M |
| Profit Margin | -397.93 |
Viridian Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $72.00 K | $75.00 K | $70.57 M | $132.00 K | $141.00 K | $284.00 K |
| Gross Profit + | $72.00 K | $75.00 K | $70.57 M | $132.00 K | $141.00 K | $284.00 K |
| Operating Income | -$93.90 M | -$106.77 M | -$40.01 M | -$122.75 M | -$116.84 M | -$126.27 M |
| EBITDA | -$93.78 M | -$106.65 M | -$39.90 M | -$122.63 M | -$116.72 M | -$126.15 M |
| Interest Expense | -$550.00 K | -$514.00 K | -$560.00 K | -$3.28 M | -$3.46 M | -$8.31 M |
| Depreciation | $117.00 K | $113.00 K | $110.00 K | $120.00 K | $121.00 K | $117.00 K |
| Income Before Tax | -$86.91 M | -$100.73 M | -$34.60 M | -$120.36 M | -$104.90 M | -$127.12 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$86.91 M | -$100.73 M | -$34.60 M | -$120.36 M | -$104.90 M | -$127.12 M |
| Net Profit Margin | -120711.11% | -134313.33% | -49.03% | -91178.03% | -74397.87% | -44760.21% |
Viridian Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $816.00 K | $817.00 K | $822.00 K | $1.02 M | $1.02 M | $1.13 M |
| Reserve & Surplus | -$1.08 B | -$1.18 B | -$1.22 B | -$1.34 B | -$1.44 B | -$1.57 B |
| Non-Current Liabilities | $22.78 M | $14.57 M | $23.47 M | $106.56 M | $101.20 M | $371.34 M |
| Current Liabilities | $33.73 M | $52.59 M | $50.70 M | $70.70 M | $51.80 M | $63.79 M |
| Total Liabilities | $56.51 M | $67.16 M | $74.17 M | $177.25 M | $153.01 M | $435.14 M |
| Fixed Assets | $1.16 M | $1.09 M | $1.13 M | $1.23 M | $1.13 M | $12.77 M |
| Current Assets | $657.24 M | $578.75 M | $571.91 M | $894.23 M | $784.74 M | $1.08 B |
| Total Assets | $660.98 M | $582.32 M | $577.14 M | $899.42 M | $789.02 M | $1.10 B |
Viridian Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$86.91 M | -$100.73 M | -$34.60 M | -$120.36 M | -$104.90 M | -$127.12 M |
| Operating Cash Flow | -$92.65 M | -$75.37 M | -$84.61 M | -$23.75 M | -$119.65 M | -$105.32 M |
| Investing Cash Flow | $100.06 M | $75.72 M | $126.08 M | -$339.42 M | $77.26 M | -$231.16 M |
| Financing Cash Flow | $9.21 M | $764.00 K | $10.86 M | $405.91 M | $6.36 M | $325.12 M |
| Change in Cash | $16.62 M | $1.11 M | $52.32 M | $42.73 M | -$36.04 M | -$11.36 M |
Viridian Therapeutics, Inc. Common Stock Return Calculator
The Viridian Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$11,681
Invested Amount$10,000
Est. Returns$1,681
About Viridian Therapeutics, Inc. Common Stock
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
Popular Stocks
FAQs
What is the share price of Viridian Therapeutics, Inc. Common Stock today?
Viridian Therapeutics, Inc. Common Stock (VRDN) share price as of October 10, 2026 is $18.28. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Viridian Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the Viridian Therapeutics, Inc. Common Stock (VRDN) Share by opening an international trading account with Angel One.
How can I purchase Viridian Therapeutics, Inc. Common Stock shares in India?
Purchasing Viridian Therapeutics, Inc. Common Stock (VRDN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Viridian Therapeutics, Inc. Common Stock (VRDN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Viridian Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of Viridian Therapeutics, Inc. Common Stock (VRDN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Viridian Therapeutics, Inc. Common Stock?
The market capitalization of Viridian Therapeutics, Inc. Common Stock on October 10, 2026, is $2.08 B.
In which sector Viridian Therapeutics, Inc. Common Stock belongs?
Viridian Therapeutics, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Viridian Therapeutics, Inc. Common Stock stocks?
In order to invest in Viridian Therapeutics, Inc. Common Stock (VRDN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
